Compare Kingsoft Cloud Holdings Limited (KC) vs Novartis AG (NVS) Price & Performance

Kingsoft Cloud Holdings LimitedTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

Kingsoft Cloud Holdings Limited vs Novartis AG — how do they compare? Kingsoft Cloud Holdings Limited trades at $10.07 (market cap $3.01B), while Novartis AG trades at $153.87 (market cap $290.25B). The key difference: Novartis AG is far larger — about 96.4× Kingsoft Cloud Holdings Limited's market cap, and Novartis AG pays a 3.17% dividend while Kingsoft Cloud Holdings Limited pays none. Which is the better fit depends on your goals.

	KC	NVS
Market Cap	$3.01B	$290.25B
Sector	Technology	Health
52-Week High	$18.21	$168.62
52-Week Low	$8.58	$113.50
Enterprise Value	$3.32B	$330.27B
Dividend Yield	—	3.17%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kingsoft Cloud Holdings Limited

Kingsoft Cloud (KC) trades at $10.04, up 5.24% today, showing strong momentum despite a bearish technical signal. The company reported Q1 2026 revenue growth of 37% year-over-year, driven by AI cloud demand, though profitability remains challenged with a -9.39% net margin. Analyst sentiment is positive with 70% buy ratings, citing potential from AI expansion and trade easing between the U.S. and China.

KC presents a growth opportunity in cloud and AI services with strong revenue acceleration, but investors face risks from persistent losses, high capital expenditure, and competitive pressures. The stock's outlook hinges on margin improvement from AI investments and sustained demand, making it suitable for growth-oriented investors tolerant of near-term volatility.

Novartis AG

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

View details →

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 21 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

About Kingsoft Cloud Holdings Limited

Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.